Sector
PharmaceuticalsOpen
₹0.95Prev. Close
₹0.91Turnover(Lac.)
₹0.1Day's High
₹0.95Day's Low
₹0.8752 Week's High
₹052 Week's Low
₹0Book Value
₹2.34Face Value
₹2Mkt Cap (₹ Cr.)
4.83P/E
8.7EPS
0.1Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Equity Capital | 11.11 | 11.11 | 11.22 | 5.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.25 | 1.52 | 1.85 | 3.41 |
Net Worth | 12.36 | 12.63 | 13.07 | 9.08 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Revenue | 1.58 | 7.54 | 9.51 | 12.09 |
yoy growth (%) | -78.94 | -20.63 | -21.36 | |
Raw materials | -2.05 | -6.61 | -9.91 | -8.34 |
As % of sales | 129.41 | 87.56 | 104.28 | 69 |
Employee costs | -0.35 | -0.76 | -0.98 | -0.86 |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Profit before tax | -0.26 | -0.73 | -4.45 | -0.02 |
Depreciation | -0.24 | -0.25 | -0.4 | -0.31 |
Tax paid | 0 | 0 | 0.35 | -0.08 |
Working capital | -1.92 | 2.24 | 3.27 | |
Other operating items |
| Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -78.94 | -20.63 | -21.36 | |
Op profit growth | 29.59 | -65.72 | -369.56 | |
EBIT growth | -30.73 | -89.74 | -510.41 | |
Net profit growth | -63.73 | -82.17 | 3,695.41 |
| Particulars (Rupees in Crores.) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
Gross Sales | 0.34 | 1.59 | 14.07 | 14.84 |
Excise Duty | 0 | 0 | 0 | 0.75 |
Net Sales | 0.34 | 1.59 | 14.07 | 14.07 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 0.72 | 1.33 | 0.93 | 0.93 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,817.6 | 158.19 | 4,36,103.12 | 863.29 | 0.74 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,783.75 | 83.58 | 1,53,540.39 | 518 | 0.52 | 2,302 | 513.62 |
Mankind Pharma Ltd MANKIND | 2,910.4 | 59.91 | 1,20,073.47 | 634.43 | 0 | 2,529.74 | 334.18 |
Cipla Ltd CIPLA | 1,475.9 | 28.16 | 1,19,195.76 | 1,178.16 | 0.88 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,401.2 | 70.36 | 1,15,106.89 | 460 | 0.82 | 2,376 | 222.38 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Vinod S Gupta
Director
Niranjan Kumar Agarwal
Whole-time Director
Manish Jatia
Additional Director
V Siva Subbu
Whole-time Director
Jatia Omprakash Manish
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Zyden Gentec Ltd
Summary
Incorporated in 1994,Overseas Capital Ltd has been engaged in Financial services.The company came out with IPO in the year 1995 and issued 21 lakhs equity shares of Rs.10 each at par.
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
